1 Min Read
Sept 18 (Reuters) - Redhill Biopharma Ltd
* RedHill Biopharma receives notice of allowance for a new U.S. patent covering its combination therapy for hard-to-treat cancers Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.